Evaluation of performance of lung cancer screening strategy in the first three rounds of the NELSON trial

The Dutch-Belgian Randomized Lung Cancer Screening Trial was designed to investigate whether screening for lung cancer by low-dose multidetector computed tomography in high-risk subjects will lead to a decrease in 10-year lung cancer mortality of at least 25% compared with a control group without screening. The study started in 2003 and Dr Nanda Horeweg of the Department of Public Health and Pulmonology at Erasmus Medical Centre in Rotterdam, Netherlands reported at the European Multidisciplinary Conference in Thoracic Oncology (EMCTO), held 9-11 May, 2013 in Lugano, Switzerland, findings from the evaluation of performance of the screening strategy in the first three rounds of the study and risk calculations made for a follow-up period of 5.5 years. Read more here.